ArticleCancers2020

Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression Treatment.

Takeshi Hatanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.